David L. Grange
CIK: 0001264908
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TNXP
Tonix Pharmaceuticals Holding Corp.
Director
Discretionary Trading P&L
Holdings
About GRANGE DAVID L
GRANGE DAVID L (SEC CIK 0001264908) files insider reports with the SEC as Director of Tonix Pharmaceuticals Holding Corp. (TNXP).
Signal8 holds 2 ownership filings by GRANGE DAVID L, all Form 4s, filed between May 15, 2025 and May 14, 2026. Those filings report 2 transactions, from May 13, 2025 to May 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on GRANGE DAVID L's filings is in BERKELEY HEIGHTS, NJ.
Recent filings by GRANGE DAVID L
Other insiders filing for Tonix Pharmaceuticals Holding Corp. (TNXP)
- Englese Thomas, Chief Commercial Officer
- BAGGER RICHARD H, Director
- SAENGER BRADLEY, Chief Financial Officer
- Taylor Carolyn E., Director
- Stillwell Richard Newcomb, Director
- LEDERMAN SETH, Chief Executive Officer